Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Bausch Health Companies Community
NYSE:BHC Community
1
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Create a narrative
Bausch Health Companies
Popular
Undervalued
Overvalued
Community Investing Ideas
Bausch Health Companies
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Refinancing And New Product Launches Will Unlock Future Possibilities
Key Takeaways Strategic initiatives in product launches and pipeline advancements suggest potential revenue growth by meeting unmet medical needs. Strong geographical revenue growth and financial flexibility through refinancing indicate potential improvements in margins and business expansion.
View narrative
US$7.50
FV
37.7% undervalued
intrinsic discount
1.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
BHC
BHC
Bausch Health Companies
Your Fair Value
US$
Current Price
US$4.67
86.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-2b
11b
2015
2018
2021
2024
2025
2027
2030
Revenue US$9.5b
Earnings US$1.4b
Advanced
Set Fair Value